Neogen (NEOG) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -66.00 |
| Nov 30, 2025 | -29.00 |
| Aug 31, 2025 | -1,431.00 |
| May 31, 2025 | -2,772.00 |
| Feb 28, 2025 | -4,207.00 |
| Nov 30, 2024 | -2,316.00 |
| Aug 31, 2024 | -1,064.00 |
| May 31, 2024 | -1,061.00 |
| Feb 29, 2024 | -939.00 |
| Nov 30, 2023 | -987.00 |
| Aug 31, 2023 | -1,076.00 |
| May 31, 2023 | -1,150.00 |
| Feb 28, 2023 | -1,186.00 |
| Nov 30, 2022 | -1,201.00 |
| Aug 31, 2022 | -866.00 |
| May 31, 2022 | -703.00 |
| Feb 28, 2022 | 137.00 |
| Nov 30, 2021 | 307.00 |
| Aug 31, 2021 | 428.00 |
| May 31, 2021 | 159.00 |
| Feb 28, 2021 | 138.00 |
| Nov 30, 2020 | 83.00 |
| Aug 31, 2020 | 120.00 |
| May 31, 2020 | 807.00 |
| Feb 29, 2020 | -106.00 |
| Nov 30, 2019 | -436.00 |
| Aug 31, 2019 | -342.00 |
| May 31, 2019 | -333.00 |
| Feb 28, 2019 | -324.00 |
| Nov 30, 2018 | -293.00 |
| Aug 31, 2018 | -358.00 |
| May 31, 2018 | -283.00 |
| Feb 28, 2018 | -291.00 |
| Nov 30, 2017 | -213.00 |
| Aug 31, 2017 | -130.00 |
| May 31, 2017 | -145.00 |
| Feb 28, 2017 | 75.00 |
| Nov 30, 2016 | -13.00 |
| Aug 31, 2016 | -135.00 |
| May 31, 2016 | -155.00 |